Silo Pharma (SILO) News Today $0.45 -0.04 (-8.84%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.44 0.00 (-0.11%) As of 04:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drugMay 21 at 7:58 PM | msn.comSilo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15May 21 at 8:55 AM | globenewswire.comSilo Pharma, Inc.: Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15May 16, 2025 | finanznachrichten.deSilo Pharma Signs With Frontage Labs For FDA Requested Safety Study Of SPC-15May 16, 2025 | nasdaq.comSilo Pharma Announces Closing of $2 Million Public OfferingMay 16, 2025 | globenewswire.comSilo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD TreatmentMay 16, 2025 | msn.comSilo Pharma, Inc. Prices Public Offering of 3,333,338 Shares with Associated WarrantsMay 15, 2025 | quiverquant.comSilo Pharma Announces Pricing of $2 Million Public OfferingMay 15, 2025 | globenewswire.comSilo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15May 14, 2025 | globenewswire.comSilo Pharma, Inc. Announces Agreement with Frontage Laboratories for SPC-15 Safety and Toxicology Study Targeting PTSD TreatmentMay 14, 2025 | quiverquant.comSilo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage LaboratoriesMay 14, 2025 | globenewswire.comSilo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia StudyApril 30, 2025 | finance.yahoo.comSilo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia StudyApril 30, 2025 | globenewswire.comSilo Pharma Files Patent Application for Alzheimer's Drug SPC-14 Targeting Novel Mechanism of ActionApril 29, 2025 | nasdaq.comSilo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s DrugApril 28, 2025 | finance.yahoo.comSilo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's DrugApril 28, 2025 | globenewswire.comSilo Pharma files to sell 4.72M shares of common stock, warrantsApril 26, 2025 | markets.businessinsider.comSilo Pharma announces first dosing in IND-enabling study for SPC-15March 27, 2025 | markets.businessinsider.comSilo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD TreatmentMarch 26, 2025 | globenewswire.comSilo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder TreatmentFebruary 26, 2025 | globenewswire.comSilo Pharma files provisional patent for SPC-15 combinationFebruary 19, 2025 | markets.businessinsider.comSilo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination TreatmentFebruary 18, 2025 | globenewswire.comSilo Pharma, Inc.: Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and FibromyalgiaFebruary 11, 2025 | finanznachrichten.deSilo Pharma reports positive early data on pain treatment implantFebruary 11, 2025 | msn.comSilo Pharma announces initial data from SP-26 studyFebruary 11, 2025 | markets.businessinsider.comSilo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and FibromyalgiaFebruary 11, 2025 | globenewswire.comSilo Pharma files provisional patent for PTSD treatmentJanuary 22, 2025 | msn.comSilo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD TreatmentJanuary 22, 2025 | globenewswire.comAfter a Patent Win, Analysts Think This Penny Stock Can Gain 465% in 2025January 14, 2025 | msn.comSilo Pharma awarded U.S. patent for PTSD treatmentJanuary 8, 2025 | markets.businessinsider.comSilo Pharma Shares Are Surging Today: What's Going On?January 8, 2025 | benzinga.comSilo Pharma shares soar on patent allowance newsJanuary 8, 2025 | investing.comSilo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical TrialJanuary 8, 2025 | markets.businessinsider.comSilo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic PainJanuary 2, 2025 | globenewswire.comSilo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and FibromyalgiaDecember 18, 2024 | globenewswire.comSilo Pharma partners with Kymanox to develop ketamine implantDecember 3, 2024 | msn.comSILO Pharma (NASDAQ:SILO) Stock, Insider Trading ActivityDecember 1, 2024 | benzinga.comSilo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain ManagementNovember 29, 2024 | globenewswire.comSilo Pharma, Inc.: Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related DisordersNovember 18, 2024 | finanznachrichten.deSilo Pharma Study Of SPC-15 Shows Potential For Depressive, Stress-Related DisordersNovember 18, 2024 | markets.businessinsider.comSilo Pharma discloses ‘promising results’ from preclinical study on SPC-15November 18, 2024 | markets.businessinsider.comSilo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related DisordersNovember 18, 2024 | globenewswire.comSilo Pharma Third Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.21 loss in 3Q 2023)November 16, 2024 | sg.finance.yahoo.comWhy 77,000 Cancer Patients Are Suing Pfizer (& Others)November 5, 2024 | msn.comSilo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine ImplantOctober 31, 2024 | globenewswire.comSilo Pharma, Inc. (SILO)October 26, 2024 | finance.yahoo.comSilo Pharma, Inc.: Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSDSeptember 10, 2024 | finanznachrichten.deSilo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSDSeptember 10, 2024 | globenewswire.comInvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO), Sever Pharma Expand Existing Agreement to Include Extrusion of Novel Ketamine Implant TherapeuticAugust 15, 2024 | msn.comHealth Care Up After Cardinal Earnings -- Health Care RoundupAugust 15, 2024 | marketwatch.com Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Email Address SILO Media Mentions By Week SILO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SILO News Sentiment▼0.680.65▲Average Medical News Sentiment SILO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SILO Articles This Week▼81▲SILO Articles Average Week Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Perfect Moment News Today MGO Global News Today Lululemon Athletica News Today ON News Today Amer Sports News Today Birkenstock News Today Gildan Activewear News Today Levi Strauss & Co. News Today The Baldwin Insurance Group News Today Kontoor Brands News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SILO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SILO Stock Free SILO Stock Alerts